Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

This study has suspended participant recruitment.
(Funding)
Sponsor:
Information provided by (Responsible Party):
Richard Junghans, PhD, MD, Roger Williams Medical Center
ClinicalTrials.gov Identifier:
NCT01723306
First received: November 1, 2012
Last updated: June 10, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)